Jazz Pharmaceuticals, Inc. (JAZZ)

Jazz Pharmaceuticals stock sees pre-market surge on positive trial results and $200M voucher sale, despite recent earnings miss and competition concerns.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing medicines.
Jazz Pharmaceuticals, Inc. uses the ticker $JAZZ for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Jazz Pharmaceuticals, Inc. (JAZZ) creators is up 63.83% from the previous week.
Jazz Pharmaceuticals, Inc. (JAZZ) engagements is up 58.5% from the previous week.
Jazz Pharmaceuticals, Inc. (JAZZ) mentions is up 49.41% from the previous week.
Jazz Pharmaceuticals, Inc. (JAZZ) posts created is up 120% from the previous week.

Price: $166.30

Price 24-Hour Time-Series Raw Data
The stock price is down -1.79% in the last [--] hours due to an earnings miss and increased competition. However, positive trial results for Ziihera and the sale of a Priority Review Voucher for $200M have caused a pre-market surge, suggesting potential upward momentum.

24-Hour: -0.47% 7-Day: 0.79% 30-Day: -1.83%

1-Year High: $180.90 on 2025-11-24
1-Year Low: $97.80 on 2025-05-09

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Jazz Pharmaceuticals, Inc. (JAZZ) is currently AltRank #1,043 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] [----]
[--] Month: [-----] +748
[--] Months: [-----] +629
[--] Year: [-----] +620
1-Year High: [-----] on 2026-02-04
1-Year Low: [--] on 2025-07-06

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +23
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-02-24
1-Year Low: [--] on 2026-02-09

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] +59%
[--] Month: [------] -41%
[--] Months: [----------] +584%
[--] Year: [----------] +581%
1-Year High: [----------] on 2025-11-24
1-Year Low: [---] on 2025-12-28

Engagements by network (24h): News: [--] YouTube: [-----] X: [-----] Reddit: [--] TikTok: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +49%
[--] Month: [---] -19%
[--] Months: [-----] -17%
[--] Year: [-----] +68%
1-Year High: [---] on 2025-06-17
1-Year Low: [--] on 2026-02-17

Mentions by network (24h): News: [--] YouTube: [--] X: [--] Reddit: [--] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Jazz Pharmaceuticals, Inc. (JAZZ) in the last [--] hours which is down 55% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +64%
[--] Month: [---] -24%
[--] Months: [-----] -34%
[--] Year: [-----] +126%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2026-01-02

The most influential creators that mention Jazz Pharmaceuticals, Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@NightOwlBiotech	[--]	[-----]	[--]	[--]
@tunemusicalmoments	[--]	[---------]	[--]	[--]
@BioPharmCatalyst	[--]	[--]	[--]	[--]

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 80%
[--] Week: 100% no change
[--] Month: 88% +10%
[--] Months: 88% -5%
[--] Year: 88% +7%
1-Year High: 100% on 2025-02-20
1-Year Low: 36% on 2025-10-01

Most Supportive Themes:

Positive Regulatory News and Approvals: (35%) Posts highlight positive regulatory events, such as FDA approvals for generic versions of Jazz Pharmaceuticals' drugs. This theme is supported by the recent FDA approval of the Zepzelca-atezolizumab combination.
Analyst Recommendations and Price Targets: (25%) Mentions of analyst ratings and price targets, which can influence investor sentiment and trading activity. This is supported by the positive sentiment and high engagement on posts discussing the stock.
Product Pipeline and Clinical Trials: (20%) Positive mentions of Jazz Pharmaceuticals' product pipeline, including Modeyso (dordavipener) and its inclusion in NCCN guidelines. This is supported by the discussions around the company's future prospects.

Most Critical Themes:

Competition and Market Dynamics: (20%) Mentions of competition in the narcolepsy market, such as Avadel's Lumryz, and the impact on Jazz Pharmaceuticals' market share. This is a concern due to the potential impact on Jazz's revenue.
Earnings Miss and Financial Performance: (10%) The company faced a miss in earnings expectations, with non-GAAP EPS of $1.68, which could be a concern for investors. This is reflected in the negative price action.

Social Dominance: 0.00142%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00142%
Daily Average: 0.013%
[--] Week: 0.00168% -0.0005200000000000001%
[--] Month: 0.005% -0.0011%
[--] Months: 0.005% -0.012%
[--] Year: 0.005% -0.0059%
1-Year High: 0.048% on 2025-06-17
1-Year Low: 0.0018% on 2026-02-16

Market Dominance: 0.011%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.011%
Daily Average: 0%
1-Year High: 0.034% on 2025-03-31
1-Year Low: 0.0083% on 2025-08-06

Market Cap: $10,105,846,442

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $10,105,846,442
Daily Average: $8,121,531,329
[--] Week: $10,105,846,442 +0.73%
[--] Month: $10,105,846,442 -1.80%
[--] Months: $10,105,846,442 +40%
[--] Year: $10,105,846,442 +25%
1-Year High: $10,992,409,484 on 2025-11-24
1-Year Low: $6,026,459,193 on 2025-05-09

Top Jazz Pharmaceuticals, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"# $MSOS https://reuters.com/article/business/healthcare-pharmaceuticals/us-approves-first-marijuana-plant-derived-drug-for-epilepsy-idUSKBN1JL298/ Enough lies. #Cannabis is a medicine. $MSOS $JAZZ U.S. approves first marijuana plant-derived drug for epilepsy https://t.co/qpaK3w1TTG "This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in https://reuters.com/article/business/healthcare-pharmaceuticals/us-approves-first-marijuana-plant-derived-drug-for-epilepsy-idUSKBN1JL298/ Enough lies. #Cannabis is a medicine. $MSOS"
X Link @anandamideGreen 2026-02-15T14:56Z [----] followers, [----] engagements

"Enough lies. #Cannabis is a medicine. $MSOS $JAZZ U.S. approves first marijuana plant-derived drug for epilepsy "This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies" said Food and Drug Administration Commissioner Scott Gottlieb. https://www.reuters.com/article/business/healthcare-pharmaceuticals/us-approves-first-marijuana-plant-derived-drug-for-epilepsy-idUSKBN1JL298/"
X Link @TheMyNotes 2026-02-14T22:54Z [----] followers, 10.4K engagements

"Time Safe Stay Epilepsy Ireland The seizure first aid song from Epilepsy Ireland designed to stick in your head. If you witness someone having a seizure the three words to remember are: Time. Safe. Stay. Listen now Remember later Learn more: https://www.epilepsy.ie/content/international-epilepsy-day-2026 Jazz Pharmaceuticals has provided a hands-off unrestricted grant to help fund the production of Epilepsy Ireland campaign materials for International Epilepsy Day. Jazz have had no involvement or input into the content of any of the materials"
YouTube Link @brainwaveepilepsy 2026-02-04T20:44Z [----] followers, 42.3K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing